Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Stockholm
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Oasmia Pharmaceutical AB

+ Add to Watchlist

OASM:SS

19.2000 SEK 0.2000 1.05%

As of 07:21:11 ET on 05/06/2015.

Company Profile for Oasmia Pharmaceutical AB (OASM)

Oasmia Pharmaceutical AB is a pharmaceutical company that specializes in human and veterinary oncology. The Company's develops the semi-synthesized substances for different therapeutic areas, primarily for anti-cancer chemotherapy. Oasmia also conducts research within antibiotics, asthma and neurologically targeted drugs in clinical or preclinical stages.

Contact Information

Oasmia Pharmaceutical AB

Vallongatan 1
Uppsala, 752 28
Sweden
Phone: 46-1850-5440
Fax: 46-1851-0873

Key Executives for Oasmia Pharmaceutical AB (OASM)

Joel Tomas CitronChairmanJulian AleksovPresident/CEO/Co-Founder
Anders BlomExec Vice PresidentMargareta ErikssonVP:Clinical Development
Ingela HagglundVP:OperationsAnnette LjungmarkHead:Accounting & Human Resources
Mikael AspHead:Quality Assurance

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil